A concise review of human brain methylome during aging and neurodegenerative diseases = A concise review of human brain methylome during aging and neurodegenerative diseases

다국어 초록 (Multilingual Abstract)

DNA methylation at CpG sites is an essential epigenetic mark that regulates gene expression during mammalian development and diseases. Methylome refers to the entire set of methylation modifications present in the whole genome. Over the last several years, an increasing number of reports on brain DNA methylome reported the association between aberrant methylation and the abnormalities in the expression of critical genes known to have critical roles during aging and neurodegenerative diseases. Consequently, the role of methylation in understanding neurodegenerative diseases has been under focus. This review outlines the current knowledge of the human brain DNA methylomes during aging and neurodegenerative diseases. We describe the differentially methylated genes from fetal stage to old age and their biological functions. Additionally, we summarize the key aspects and methylated genes identified from brain methylome studies on neurodegenerative diseases. The brain methylome studies could provide a basis for studying the functional aspects of neurodegenerative diseases. [BMB Reports 2019; 52(10): 577-588]

참고문헌 (Reference)

1 Nan X, "Transcriptional repression by the methyl-CpG-binding protein MeCP2involves a histone deacetylase complex" 393 : 386-, 1998

2 Walsh CP, "Transcription of IAP endogenous retroviruses is constrained by cytosine methylation" 20 : 116-, 1998

3 Zhang L, "Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA" 8 : 328-, 2012

4 Hotchkiss RD, "The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography" 175 : 315-332, 1948

5 Kriaucionis S, "The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain" 324 : 929-930, 2009

6 Lord J, "The epigenetic landscape of Alzheimer's disease" 17 : 1138-, 2014

7 Horvath S, "The cerebellum ages slowly according to the epigenetic clock" 7 : 294-, 2015

8 He YF, "Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA" 333 : 1303-1307, 2011

9 Ito S, "Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine" 333 : 1300-1303, 2011

10 Santiago M, "TET enzymes and DNA hydroxymethylation in neural development and function—how critical are they?" 104 : 334-340, 2014

11 배재열, "Synapses in neurodegenerative diseases" 생화학분자생물학회 50 (50): 237-246, 2017

12 Gruenbaum Y, "Substrate and sequence specificity of a eukaryotic DNA methylase" 295 : 620-, 1982

13 Ito S, "Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification" 466 : 1129-, 2010

14 Bhutani N, "Reprogramming towards pluripotency requires AID-dependent DNA demethylation" 463 : 1042-, 2010

15 Boyes J, "Repression of genes by DNA methylation depends on CpG density and promoter strength : evidence for involvement of a methyl‐CpG binding protein" 11 : 327-333, 1992

16 Wyatt G, "Recognition and estimation of 5-methylcytosine in nucleic acids" 48 : 581-, 1951

17 Sanchez‐Mut JV, "Promoter hypermethylation of the phosphatase DUSP22 mediates PKA‐dependent TAU phosphorylation and CREB activation in Alzheimer's disease" 24 : 363-368, 2014

18 Kalia LV, "Parkinson's disease" 386 : 896-912, 2015

19 Swain JL, "Parental legacy determines methylation and expression of an autosomal transgene : a molecular mechanism for parental imprinting" 50 : 719-727, 1987

20 Illingworth RS, "Orphan CpG islands identify numerous conserved promoters in the mammalian genome" 6 : e1001134-, 2010

21 Delgado-Morales R, "Opening up the DNA methylome of dementia" 22 : 485-, 2017

22 Antequera F, "Number of CpG islands and genes in human and mouse" 90 : 11995-11999, 1993

23 Lindberg RL, "Multiple sclerosis as a generalized CNS disease—comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS" 152 : 154-167, 2004

24 Faguy K, "Multiple sclerosis : An update" 87 : 529-550, 2016

25 Spiers H, "Methylomic trajectories across human fetal brain development" 25 : 338-352, 2015

26 Lunnon K, "Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease" 17 : 1164-, 2014

27 Gartler SM, "Mammalian X-chromosome inactivation" 17 : 155-190, 1983

28 Nalls MA, "Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease" 46 : 989-, 2014

29 Ioshikhes IP, "Large-scale human promoter mapping using CpG islands" 26 : 61-, 2000

30 Galpern WR, "Interface between tauopathies and synucleinopathies : a tale of two proteins" 59 : 449-458, 2006

31 Consortium IHGS, "Initial sequencing and analysis of the human genome" 409 : 860-, 2001

32 Mastronardi FG, "Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination : a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation" 26 : 11387-11396, 2006

33 Villar-Menéndez I, "Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A 2A R levels in Huntington’s disease" 15 : 295-309, 2013

34 Xi Z, "Hypermethylation of the CpG-island near the C9orf72 G4C2-repeat expansion in FTLD patients" 23 : 5630-5637, 2014

35 Russ J, "Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier" 129 : 39-52, 2015

36 McColgan P, "Huntington's disease : a clinical review" 25 : 24-34, 2018

37 Bates GP, "Huntington disease" 1 : 15005-, 2015

38 Sanchez-Mut JV, "Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns" 6 : e718-, 2016

39 Lister R, "Human DNA methylomes at base resolution show widespread epigenomic differences" 462 : 315-, 2009

40 Lister R, "Global epigenomic reconfiguration during mammalian brain development" 341 : 1237905-, 2013

41 Reik W, "Genomic imprinting determines methylation of parental alleles in transgenic mice" 328 : 248-, 1987

42 Hannum G, "Genome-wide methylation profiles reveal quantitative views of human aging rates" 49 : 359-367, 2013

43 Bakulski KM, "Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex" 29 : 571-588, 2012

44 Kaut O, "Genome-scale methylation analysis of Parkinson's disease patients'brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1" 13 : 87-91, 2012

45 van Eijk KR, "Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects" 13 : 636-, 2012

46 Giri M, "Genes associated with Alzheimer’s disease : an overview and current status" 11 : 665-, 2016

47 Davies MN, "Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood" 13 : R43-, 2012

48 Huynh JL, "Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains" 17 : 121-, 2014

49 Rao J, "Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients" 2 : e132-, 2012

50 Portela A, "Epigenetic modifications and human disease" 28 : 1057-, 2010

51 Levine ME, "Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer’s disease related cognitive functioning" 7 : 1198-, 2015

52 Laurent L, "Dynamic changes in the human methylome during differentiation" 20 : 320-331, 2010

53 Feng J, "Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons" 13 : 423-, 2010

54 Guo JU, "Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain" 17 : 215-, 2014

55 Masliah E, "Distinctive patterns of DNA methylation associated with Parkinson disease : identification of concordant epigenetic changes in brain and peripheral blood leukocytes" 8 : 1030-1038, 2013

56 Heyn H, "Distinct DNA methylomes of newborns and centenarians" 109 : 10522-10527, 2012

57 Hernandez DG, "Distinct DNA methylation changes highly correlated with chronological age in the human brain" 20 : 1164-1172, 2011

58 Day K, "Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape" 14 : R102-, 2013

59 Hsieh CL, "Dependence of transcriptional repression on CpG methylation density" 14 : 5487-5494, 1994

60 Jähner D, "De novo methylation and expression of retroviral genomes during mouse embryogenesis" 298 : 623-, 1982

61 Veldic M, "DNAmethyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains" 101 : 348-353, 2004

62 Okano M, "DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development" 99 : 247-257, 1999

63 Horvath S, "DNA methylation-based biomarkers and the epigenetic clock theory of ageing" 19 : 371-, 2018

64 정상은, "DNA methylation-based age prediction from various tissues and body fluids" 생화학분자생물학회 50 (50): 546-553, 2017

65 Ladd-Acosta C, "DNA methylation signatures within the human brain" 81 : 1304-1315, 2007

66 Numata S, "DNA methylation signatures in development and aging of the human prefrontal cortex" 90 : 260-272, 2012

67 De Souza RA, "DNA methylation profiling in human Huntington's disease brain" 25 : 2013-2030, 2016

68 Sanchez-Mut JV, "DNA methylation map of mouse and human brain identifies target genes in Alzheimer’s disease" 136 : 3018-3027, 2013

69 Siegmund KD, "DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons" 2 : e895-, 2007

70 Heyward FD, "DNA methylation in memory formation : emerging insights" 21 : 475-489, 2015

71 Bird AP, "DNA methylation and the frequency of CpG in animal DNA" 8 : 1499-1504, 1980

72 Day JJ, "DNA methylation and memory formation" 13 : 1319-, 2010

73 Horvath S, "DNA methylation age of human tissues and cell types" 14 : 3156-, 2013

74 Rai K, "DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45" 135 : 1201-1212, 2008

75 Bhutani N, "DNA demethylation dynamics" 146 : 866-872, 2011

76 Tahiliani M, "Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1" 324 : 930-935, 2009

77 Ling SC, "Converging mechanisms in ALS and FTD : disrupted RNA and protein homeostasis" 79 : 416-438, 2013

78 Domcke S, "Competition between DNA methylation and transcription factors determines binding of NRF1" 528 : 575-, 2015

79 Dawlaty MM, "Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development" 24 : 310-323, 2013

80 Pedre X, "Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions" 31 : 3435-3445, 2011

81 Liu EY, "C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD" 128 : 525-541, 2014

82 Hermann A, "Biochemistry and biology of mammalian DNA methyltransferases" 61 : 2571-2587, 2004

83 Yu M, "Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome" 149 : 1368-1380, 2012

84 Cho S, "Association of miR-938G＞ A polymorphisms with primary ovarian insufficiency(POI)-related gene expression" 18 : 1255-, 2017

85 Yu L, "Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease" 72 : 15-24, 2015

86 Lippa CF, "Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease" 45 : 353-357, 1999

87 Levine ME, "An epigenetic biomarker of aging for lifespan and healthspan" 10 : 573-, 2018

88 Chibnik LB, "Alzheimer's loci : epigenetic associations and interaction with genetic factors" 2 : 636-647, 2015

89 De Jager PL, "Alzheimer's disease : early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci" 17 : 1156-, 2014

90 Counts JL, "Alterations in DNA methylation may play a variety of roles in carcinogenesis" 83 : 13-15, 1995

91 Horvath S, "Aging effects on DNA methylation modules in human brain and blood tissue" 13 : R97-, 2012

92 Trinh J, "Advances in the genetics of Parkinson disease" 9 : 445-, 2013

93 Gibbs JR, "Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain" 6 : e1000952-, 2010

94 Belzil VV, "ALS and FTD : an epigenetic perspective" 132 : 487-502, 2016

95 Consortium IPsDG, "A two-stage meta-analysis identifies several new loci for Parkinson's disease" 7 : e1002142-, 2011

96 Illingworth R, "A novel CpG island set identifies tissue-specific methylation at developmental gene loci" 6 : e22-, 2008

97 Rauch TA, "A human B cell methylome at 100− base pair resolution" 106 : 671-678, 2009

98 Saxonov S, "A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters" 103 : 1412-1417, 2006